BioLine Rx Cash from Financing (TTM) Analysis

BioLine Rx Ltd (BLRX)

0.68 +0.02 (+3.01%) USD | NASDAQ | May 03, 16:00

0.6783 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2010. Upgrade now.

Date	Value
December 31, 2023	15.06M
September 30, 2023	2.669M
June 30, 2023	21.89M
March 31, 2023	21.33M
December 31, 2022	20.44M
September 30, 2022	21.26M
June 30, 2022	0.117M
March 31, 2022	14.90M
December 31, 2021	57.75M
September 30, 2021	64.52M
June 30, 2021	61.90M
March 31, 2021	59.39M
December 31, 2020	17.87M
September 30, 2020	13.51M
June 30, 2020	15.44M
March 31, 2020	4.664M
December 31, 2019	19.19M
September 30, 2019	26.88M
June 30, 2019	26.02M
March 31, 2019	26.61M
December 31, 2018	13.10M
September 30, 2018	3.807M
June 30, 2018	13.22M
March 31, 2018	38.02M
December 31, 2017	38.68M

Date	Value
September 30, 2017	38.26M
June 30, 2017	28.81M
March 31, 2017	2.582M
December 31, 2016	2.09M
September 30, 2016	1.71M
June 30, 2016	2.391M
March 31, 2016	4.601M
December 31, 2015	29.49M
September 30, 2015	39.33M
June 30, 2015	38.67M
March 31, 2015	36.48M
December 31, 2014	32.64M
September 30, 2014	23.67M
June 30, 2014	25.08M
March 31, 2014	26.18M
December 31, 2013	15.07M
September 30, 2013	16.53M
June 30, 2013	15.00M
March 31, 2013	13.17M
December 31, 2012	15.77M
September 30, 2012	13.24M
June 30, 2012	13.33M
March 31, 2012	14.04M
December 31, 2011	-0.0807M
September 30, 2011	-0.069M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.117M

Minimum

Jun 2022

64.52M

Maximum

Sep 2021

25.52M

Average

20.44M

Median

Dec 2022

Cash from Financing (TTM) Benchmarks